fda warning letters compounded semaglutide september 2025 Navigating Semaglutide: What Health Care Providers Need to Know FDA issued 25 warning letters

These frequent check-ins, typically once a week or once every two weeks, allow providers to monitor weight, skin changes, and side effects

The Area Postrema: How Your Brain Senses the Medicine GLP-1 medications also work by activating GLP-1 receptors, which play a role in managing your appetite and food cravings

Point-of-care gastric ultrasound has become a valuable tool that identifies patients with higher aspiration risk [35]

TRIUMPH-4 has already delivered positive topline results

It has recently been shown that a PEGylated GLP-1R/GcgR co-agonist could restore leptin sensitivity in DIO mice chronically maintained on a high-fat diet [73], and this may constitute one of the inherent weight-lowering actions of the co-agonist

Retatrutide is managed under medical supervision, and dosing decisions are made by a qualified healthcare provider